Source: http://health.yahoo.net/news/s/nm/orexigen-fda-agree-on-trial-design-for-obesity-drug
Monday, 6 February 2012
Orexigen, FDA agree on trial design for obesity drug
(Reuters) - Orexigen Therapeutics Inc said it reached an agreement with U.S. health regulators on the design of a heart-safety trial required for the approval of its experimental obesity drug. The biopharmaceutical company plans to enroll about 10...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.